The DOI matches its Crossref record; 78 of the 86 references it cites were found in a registry or an index.
Chk2/hCds1 functions as a DNA damage checkpoint in G1by stabilizing p53
Open accessAbstract
Chk2/hcds1, the human homolog of the Saccharomyces cerevisiae RAD53/SPK1 and Schizosaccharomyces pombe cds1 DNA damage checkpoint genes, encodes a protein kinase that is post-translationally modified after DNA damage. Like its yeast homologs, the Chk2/hCds1 protein phosphorylates Cdc25C in vitro, suggesting that it arrests cells in G 2 in response to DNA damage. We expressed Chk2/hCds1 in human cells and analyzed their cell cycle profile. Wild-type, but not catalytically inactive, Chk2/hCds1 led to G 1 arrest after DNA damage. The arrest was inhibited by cotransfection of a dominant-negative p53 mutant, indicating that Chk2/hCds1 acted upstream of p53. In vitro, Chk2/hCds1 phosphorylated p53 on Ser-20 and dissociated preformed complexes of p53 with Mdm2, a protein that targets p53 for degradation. In vivo, ectopic expression of wild-type Chk2/hCds1 led to increased p53 stabilization after DNA damage, whereas expression of a dominant-negative Chk2/hCds1 mutant abrogated both phosphorylation of p53 on Ser-20 and p53 stabilization. Thus, in response to DNA damage, Chk2/hCds1 stabilizes the p53 tumor suppressor protein leading to cell cycle arrest in G 1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and hChk2, in turn, phosphorylates yet another amino-terminal Ser residue (Ser 20) in p53”
From Cell cycle checkpoint signaling through the ATM and ATR kinases (2001) · cites this paper as Chehab et al. 2000
In the citing paper
“These phosphorylation events contribute to disrupting the p53-Mdm2 (Chehab et al., 2000; Shieh et al., 2000), and Mdm2-DAXX (Tang et al., 2013) interactions, as well as to the degradation of Mdm2 and Mdm4 (Stommel and Wahl, 2004; Chen et al., 2005; Pereg et al., 2005, 2006; LeBron et al., 2006).”
From USP7 Is a Master Regulator of Genome Stability (2020) · cites this paper as Chehab et al., 2000
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on serine 20 and inhibits MDM2 binding (Shieh et al, 1997;Banin et al, 1998;Chehab et al, 2000;Shieh et al, 2000).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Chehab et al, 2000
In the citing paper
“Studies using Chk2-null mice, Chk2-null HCT116 cells, and Chk2 siRNA resulted in different conclusions (Zhang et al, 1998;Chehab et al, 2000;Shieh et al, 2000;Ahn et al, 2003; Jallepalli et al, 2003).”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Chehab et al, 2000
In the citing paper
“Although a role of ATM in p53 response is well established, the significance of Chk2 is still a matter of debate.”
From ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage (2005) · cites this paper as Chehab et al, 2000
In the citing paper
“ATM also activates Chk2, which in turn phosphorylates p53 on S20, which is a part of the MDM2-binding site (Shieh et al, 1997(Shieh et al, , 2000;;Banin et al, 1998;Chehab et al, 2000).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Chehab et al, 2000
In the citing paper
“p53 is phosphorylated at Ser20 by the checkpoint kinase Chk2 after IR, which results in p53's dissociation from Mdm2 and its subsequent stabilization”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Chehab et al., 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 2×
“Stabilization of p53 in cells exposed to IR or UV light is due to dissociation from Mdm2 (Shieh et al. 1997), a protein that targets p53 for degradation through the ubiquitin pathway (Haupt et al. 1997; Kubbutat et al. 1997; Midgley and Lane 1997).”
BackgroundMomand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
Flagged first, then by citations
8 of the 86 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 805
Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence
Scanlan, R.-L., Pease, L., O’Keefe, H., Guimera, A. M., Rasmussen, L. J., Wordsworth, J., & Shanley, D. P. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1448543 · Cited by 11
ATM and ATR checkpoint kinase pathways: A concise review
Chauhan, N., Wagh, V., Joshi, P., & Jariyal, H. (2020) · Advances in Human Biology · doi:10.4103/aihb.aihb_78_19 · Cited by 9
Sadri, N., Surrey, L. F., Fraker, D. L., & Zhang, P. J. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-014-1563-0 · Cited by 10
Mechanisms of Gastrointestinal Malignancies
Katona, B. W., & Lynch, J. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00066-9 · Cited by 11
Zhang, B., Cui, B., Du, J., Shen, X., Wang, K., Chen, J., Xiao, L., Sun, C., & Li, Y. (2019) · Cancer Management and Research · doi:10.2147/cmar.s187099 · Cited by 10
Kwon, H.-J., Kim, L., Ahn, C., Yang, I., Hong, K., Hong, S., Shin, J., & Cho, S. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.19-28 · Cited by 10
Thelestam, M., & Frisan, T. (2006) · Elsevier eBooks · doi:10.1016/b978-012088445-2/50028-7 · Cited by 10
Dass, C. R., Tan, M. L., Galloway, S. J., & Choong, P. (2010) · Oligonucleotides · doi:10.1089/oli.2009.0224 · Cited by 10
Hereditary breast cancer syndromes and clinical implications
Majdak-Paredes, E. J., & Fatah, F. (2008) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2008.07.012 · Cited by 11
Yamauchi, M., Suzuki, K., Kodama, S., & Watanabe, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.175 · Cited by 10
NOVEL TARGETS IN THE CELL CYCLE AND CELL CYCLE CHECKPOINTS
Pommier, Y. G., Yu, Q., & Kohn, K. W. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50003-6 · Cited by 11
Zheng, Y., Li, L., Shen, H., Sturgis, E. M., Eicher, S. A., Strom, S. S., Spitz, M. R., & Wei, Q. (2001) · Carcinogenesis · doi:10.1093/carcin/22.12.2005 · Cited by 10
Nyberg, K. A., Michelson, R. J., Putnam, C. W., & Weinert, T. A. (2002) · Cited by 10
Insights into the genetic landscape of pheochromocytomas and paragangliomas in a Brazilian cohort
Fagundes, G. F. C., Freitas-Castro, F., de Santana, L. S., Ledesma, F. L., Petenuci, J., Afonso, A. C. F., Pereira, C. A. A., Maciel, A. A. W., Soares, I. C., Gomes, N. L., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae160 · Cited by 11
Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia
Nicot, C. (2015) · International Journal of Cancer and Oncology · doi:10.15436/2377-0902.15.017 · Cited by 12
Identification of dAven, aDrosophila melanogasterortholog of the cell cycle regulator Aven
Zou, S., Chang, J. W., LaFever, L., Tang, W., Johnson, E. L., Hu, J., Wilk, R., Krause, H. M., Drummond‐Barbosa, D., & Irusta, P. M. (2011) · Cell Cycle · doi:10.4161/cc.10.6.15080 · Cited by 9
CHEK2 mutation in a patient with pancreatic adenocarcinoma—a rare case report
Vittal, A., Saha, D., Samanta, I., & Kasi, A. (2021) · AME Case Reports · doi:10.21037/acr-20-83 · Cited by 9
Leaf extract of Osbeckia octandra induces apoptosis in oral squamous cell carcinoma cells
Kim, J. Y., Kim, J., Bandara, B. M. R., Tilakaratne, W. M., & Kim, D. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03505-4 · Cited by 9
Induction of DNA Repair Genes in Mammalian Cells in Response to Genotoxic Stress
Christmann, M., Fritz, G., & Kaina, B. (2006) · Springer eBooks · doi:10.1007/7050_014 · Cited by 9
A Novel Role for Thyroid Hormone Receptor Beta in Cellular Radiosensitivity
Matsuse, M., Saenko, V., Sedliarou, I., Rogounovitch, T., Nakazawa, Y., Mitsutake, N., Akulevich, N. M., Namba, H., & Yamashita, S. (2008) · Journal of Radiation Research · doi:10.1269/jrr.07065 · Cited by 9
Sunkaria, A., Wani, W. Y., Sharma, D. R., & Gill, K. D. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23173 · Cited by 9
Reynolds, R. P., Witherspoon, S. M., & Fox, T. R. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20017 · Cited by 9
Uth, K., & Sleigh, R. (2014) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2014.915155 · Cited by 8
Scafoglio, C., Smolka, M. B., Zhou, H., Perissi, V., & Rosenfeld, M. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059986 · Cited by 8
4-Hydroxy TEMPO Attenuates Dichlorvos Induced Microglial Activation and Apoptosis
Sunkaria, A., Sharma, D. R., Wani, W. Y., & Gill, K. D. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400206w · Cited by 8
Simulated Annealing Based Algorithm for Identifying Mutated Driver Pathways in Cancer
Li, H., Zhang, Y.-L., Zheng, C.-H., & Wang, H. (2014) · BioMed Research International · doi:10.1155/2014/375980 · Cited by 8
Qin, D., Lee, H., Yuan, C., Ju, Y., & Tsai, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.076 · Cited by 8
BRCA-1, BRCA-2 and Hereditary Breast Cancer
Bove, B. A., Dunbrack, R. L., & Godwin, A. K. (2002) · CRC Press eBooks · doi:10.1201/b14039-20 · Cited by 8
Tissue-Specific Regulation of Chk1 Expression by p53
Cheung, K.-J., & Li, G. (2001) · Experimental and Molecular Pathology · doi:10.1006/exmp.2001.2398 · Cited by 8
Minor Kinases with Major Roles in Cytokinesis Regulation
Sechi, S., Piergentili, R., & Giansanti, M. G. (2022) · Cells · doi:10.3390/cells11223639 · Cited by 8
Cellular response to alkylating agent MNNG is impaired in STAT 1‐deficients cells
Koon, L. A., Lesage, D., Lemadre, E., Souissi, I., Fagard, R., Varin‐Blank, N., Fabre, E. E., & Schischmanoff, P. O. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12887 · Cited by 7
Monitoring the Activation of the DNA Damage Response Pathway in a 3D Spheroid Model
Mondésert, O., Frongia, C., Clayton, O., Boizeau, M.-L., Lobjois, V., & Ducommun, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134411 · Cited by 7
Nuclear Localization Signal and p53 Binding Site in MAP/ERK Kinase Kinase 1 (MEKK1)
Chipps, E., Protzman, A. D., Muhi, M. Z., Ando, S., Calvet, J. P., & Islam, M. R. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25238 · Cited by 7
ATM: From Phenotype to Functional Genomics — And Back
Shiloh, Y. (2002) · Springer eBooks · doi:10.1007/978-3-662-04667-8_4 · Cited by 7
High pATM is Associated With Poor Local Control in Supraglottic Cancer Treated With Radiotherapy
de Bruin, L. B., Schuuring, E. M. D., de Bock, G. H., Slagter‐Menkema, L., Mastik, M. F., Noordhuis, M. G., Langendijk, J. A., Kluin, P. M., & van der Laan, B. F. A. M. (2020) · The Laryngoscope · doi:10.1002/lary.28641 · Cited by 7
Tissue-specific regulation of checkpoint kinase 2 expression by p53
Chin, M. Y., & Li, G. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00088-1 · Cited by 7
p53 N-Terminal Ser-15∼P and Ser-20∼P Levels in Squamous Cell Lung Cancer after Radio/Chemotherapy
Mróz, R. M., Hołownia, A., Chyczewska, E., Chyczewski, L., & Braszko, J. J. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0077oc · Cited by 8
Overexpression of RFT induces G1–S arrest and apoptosis via p53/p21Waf1 pathway in glioma cell
Kano, H., Arakawa, Y., Takahashi, J. A., Nozaki, K., Kawabata, Y., Takatsuka, K., Kageyama, R., Ueba, T., & Hashimoto, N. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.120 · Cited by 7
BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer
Sólyom, S. (2011) · Cited by 7
Modelling the p53 gene regulatory network.
Brewer, D. S. (2006) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 7
Mechanisms of DNA Damage Response in Mammalian Oocytes
Sun, F., Šutovský, P., Patterson, A. L., & Balboula, A. Z. (2024) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-031-55163-5_3 · Cited by 6
Chk2 Protects against Radiation-Induced Genomic Instability
MacLaren, A., Slavin, D. A., & McGowan, C. H. (2009) · Radiation Research · doi:10.1667/rr1603.1 · Cited by 6
Kishi, S. (2006) · Elsevier eBooks · doi:10.1016/b978-012369391-4/50029-1 · Cited by 6
Baloch, A. H., Khosa, A. N., Bangulzai, N., Shuja, J., Naseeb, H. K., Jan, M., Marghazani, I. B., Kakar, M.-U.-H., Baloch, D. M., Cheema, A. M., et al. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2016.17.3.1089 · Cited by 6
Moolmuang, B., & Ruchirawat, M. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaa050 · Cited by 6
Molecular targets for cell cycle inhibition and cancer therapy
Lee, M., & Yang, H.-Y. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.3.329 · Cited by 6
Diverse functions of BRCA1 in the DNA damage response
Lee, J., & Chung, J. H. (2001) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399401003131 · Cited by 6
Lethal Errors in Checkpoint Control: Life without Chk1
Zachos, G., Rainey, M. D., & Gillespie, D. A. (2003) · Cell Cycle · doi:10.4161/cc.2.1.277 · Cited by 6
Mechanisms of hepatocarcinogenesis in chronic hepatitis C
Mitchell, J. K., & McGivern, D. R. (2014) · Hepatic Oncology · doi:10.2217/hep.14.7 · Cited by 6
Shefrin, S., Sari, A. N., Kumar, V., Zhang, H., Meidinna, H. N., Kaul, S. C., Wadhwa, R., & Sundar, D. (2022) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2022.09.002 · Cited by 5
González-Marín, B., Calderón-Segura, M. E., & Sekelsky, J. J. (2023) · Toxics · doi:10.3390/toxics11090754 · Cited by 7
Mutation analysis of the checkpoint kinase 2 gene in colorectal cancer cell lines
Liu, W., Zhong, B., Yang-de, Z., & Choi, G. (2007) · Chinese Medical Journal · doi:10.1097/00029330-200712010-00010 · Cited by 5
Regulation of Cell Cycle Progression
Scorah, J., & McGowan, C. H. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00302-8 · Cited by 6
Oscillatory Behaviors of Delayed p53 Regulatory Network with microRNA 192 in DNA Damage Response
Gao, C., & Chen, F. (2021) · International Journal of Bifurcation and Chaos · doi:10.1142/s0218127421500206 · Cited by 5
Fayaz, S., Fard‐Esfahani, P., & Torbati, P. M. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.12.5019 · Cited by 5
Genetic Mutations Associated with Breast Cancer in Pakistan
Pervaiz, R. (2017) · Malaysian Journal of Medical and Biological Research · doi:10.18034/mjmbr.v4i2.439 · Cited by 5
The absence of a functional relationship between ATM and BLM, the components of BASC, in DT40 cells
Wang, W., Seki, M., Otsuki, M., Tada, S., Takao, N., Yamamoto, K.-I., Hayashi, M., Honma, M., & Enomoto, T. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2003.11.008 · Cited by 5
Breast Cancer Genetics for Plastic Surgeons
McInerney, N. M., Narod, S. A., Metcalfe, K. A., Semple, J. L., & Brown, M. H. (2017) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000003577 · Cited by 4
Splicing DNA Damage Adaptations for the Management of Cancer Cells
Singh, A. K., Yadav, D., & Malviya, R. (2023) · Current Gene Therapy · doi:10.2174/0115665232258528231018113410 · Cited by 4
Assessing G1-to-S-Phase Progression After Genotoxic Stress
DeRan, M., Pulvino, M. J., & Zhao, J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-273-1_16 · Cited by 4
MDM2: RING Finger Protein and Regulator of p53
Wu, L., & Maki, C. G. (2005) · Springer eBooks · doi:10.1007/0-387-27421-9_34 · Cited by 4
Efficient Gaussian sample specific network marker discovery and drug enrichment analysis validation
Liu, W., Du, Y., Fang, G., Kou, Z., Wang, X., & Han, H. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.107139 · Cited by 4
Sahay, O., Barik, G. K., Sharma, T., Pillai, A. D., Rapole, S., & Santra, M. K. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103261 · Cited by 4
Revia, S., Budzinska, M. A., Bogatyrova, O., Neumann, F., Zimmermann, A., Amendt, C., & Albers, J. (2023) · Cancers · doi:10.3390/cancers16010189 · Cited by 5
Zhang, S., Qian, Y., Liu, A., Cai, J., Zhao, X.-L., Wei, J., & Zhu, M.-H. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.08.019 · Cited by 4
Lynch, J. P., & Rustgi, A. K. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382026-6.00080-4 · Cited by 4
Molecular Mechanisms of DNA Damage and Repair in Ischemic Neuronal Injury
Sun, F., Gobbel, G. T., Li, W., & Chen, J. (2006) · Springer eBooks · doi:10.1007/978-0-387-30383-3_5 · Cited by 4
Hereditary Breast Cancer Syndromes: Molecular Pathogenesis and Diagnostics
Vos, S., van Diest, P. J., van der Wall, E., & van Diest, P. J. (2015) · Wiley eBooks · doi:10.1002/9780470015902.a0005375 · Cited by 4
p53 in Human Cancer — Somatic and Inherited Mutations and Mutation-independent Mechanisms
Moll, U. M., & Concin, N. (2007) · Springer eBooks · doi:10.1007/0-387-30127-5_6 · Cited by 3
Soleimani, T., Engwall, A. J., Bourdon, C., Torabi, M. A., & Fortes, T. A. (2021) · Breast Care · doi:10.1159/000513679 · Cited by 3
Molecular Genetics of Breast Cancer
Ingvarsson, S. (2003) · International Journal of Human Genetics · doi:10.31901/24566330.2003/03.02.01 · Cited by 4
DNA Damage Signaling Downstream of ATM
Bunz, F. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8044-1_2 · Cited by 4
Levine, A. J., Bargonetti, J., Bond, G. L., Hoh, J. J., Onel, K., Overholtzer, M., Stoffel, A., Teresky, A. K., Walsh, C. A., & Jin, S. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5_1 · Cited by 3
Isolation and functional analysis of a chk2 homologue from Entamoeba histolytica
Iwashita, J., Sato, Y., Kobayashi, S., Takeuchi, T., & Abé, T. (2004) · Parasitology International · doi:10.1016/j.parint.2004.08.002 · Cited by 3
Wu, R. T. Y., & Cheng, W. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-418680-4.00021-x · Cited by 4
p53 Induction as an Indicator of DNA Damage
Selivanova, G. (2003) · Humana Press eBooks · doi:10.1385/1-59259-179-5:279 · Cited by 3
Establishment of a Cell-Free System to Study the Activation of Chk2
Xu, X., & Stern, D. F. (2004) · Humana Press eBooks · doi:10.1385/1-59259-788-2:165 · Cited by 3
Functional Rescue of Mutant p53 as a Strategy to Combat Cancer
Selivanova, G., & Wiman, K. G. (2002) · Elsevier eBooks · doi:10.1016/b978-012476249-7/50021-7 · Cited by 3
Regulation of p53 Activity and Associated Checkpoint Controls
Post, S. M., Quintás‐Cardama, A., & Lozano, G. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_11 · Cited by 2
Paluschinski, M., Castoldi, M., Schöler, D., Bardeck, N., Oenarto, J., Görg, B., & Häussinger, D. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0204 · Cited by 2
Role of Tumor Suppressors in DNA Damage Response
Zhou, B. S., Mattern, M. R., & Khanna, K. K. (2003) · Humana Press eBooks · doi:10.1385/1-59259-329-1:39 · Cited by 2
DNA Damage Response and the Balance Between Cell Survival and Cell Death
Kaina, B., Roos, W. P., & Christmann, M. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_7 · Cited by 2
Drané, P., Álvarez, S. P., Meiller, A., & May, E. (2002) · Médecine Nucléaire · Cited by 2
Knops, K. (2013) · DuEPublico (University of Duisburg-Essen) · Cited by 2
Genetics of Male Breast Cancer
Fentiman, I. S. (2025) · Springer eBooks · doi:10.1007/978-3-031-89929-4_3 · Cited by 1
WDFY2 promotes MRN complex formation required for homologous recombination-mediated DNA repair
Lu, Y.-F., Tang, H., Di, L., Yerkinkazhina, Y., Su, J., Tang, M., Qian, J., Zeng, R., Shu, Y., He, X., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116520 · Cited by 1
Genomic, epigenomic and transcriptomic regulation of cellular senescence
Salekeen, R., Kieu, T. L., Robbins, P. D., Niedernhofer, L. J., & Laux, L. (2026) · Nature Reviews Genetics · doi:10.1038/s41576-026-00982-y · Cited by 2
MOLECULAR GENETICS OF SOFT TISSUE TUMORS
Lasota, J. P. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781049.006 · Cited by 1
Dzērvīte, A., Pranka, M., Lāce, T., Rungule, R., Miklaševičs, E., & Gardovskis, J. (2012) · Acta Chirurgica Latviensis · doi:10.2478/v10163-012-0001-0 · Cited by 1
Lung cancer drug resistance and DNA damage signaling
Zhang, P. (2005) · Therapy · doi:10.1586/14750708.2.3.381 · Cited by 1
DNA damage response genes and chromosome 11q21-q24 candidate tumor suppressor genes in breast cancer
Allinen, M. (2002) · Cited by 1
Targeting Myc-driven tumours - BETing on ATR
Muralidharan, S. V. (2016) · Cited by 1
Petkova, R., Chelenkova, P., Tournev, I., & Chakarov, S. (2016) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2016.1179593 · Cited by 1
BRCA-1, BRCA-2, and Hereditary Breast Cancer
Betsy A. Bove, R. L. D., Jr. (2002) · CRC Press eBooks · doi:10.3109/9780203909249-22 · Cited by 1
Shaltiël, I. A., Llopis, A., Aprelia, M., Klompmaker, R., Menegakis, A., Krenning, L., & Medema, R. H. (2021) · Cells · doi:10.3390/cells10030550 · Cited by 1
Mir, M. A., & Sofi, S. (2023) · Springer eBooks · doi:10.1007/978-981-19-8911-7_4 · Cited by 2
Cell Cycle Regulation and DNA Damage
Sakasai, R., & Tibbetts, R. S. (2009) · Springer eBooks · doi:10.1007/978-90-481-2561-6_5 · Cited by 1
Genetic Syndromes and Radiotherapy in Breast Cancer
Green, C., Khan, A. J., & Haffty, B. G. (2015) · Medical radiology · doi:10.1007/174_2014_1046 · Cited by 1
In vitro phosphorylation of BRCA2 by the checkpoint kinase CHEK2
Kim, S., Mohapatra, G., & Haber, D. A. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604644 · Cited by 2
Regulation of Cell Cycle Progression
McGowan, C. H. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50691-4 · Cited by 1
Metadata
- Authors
- Chehab, N. H., Malikzay, A., Appel, M., & Halazonetis, T. D.
- Affiliations
- The Wistar Institute (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2000-02-01
- Volume
- 14
- Issue
- 3
- Pages
- 278-288
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- PMC
- PMC316357
- OpenAlex
- W2131833681
- Cited by
- 805
- References
- 86
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 8 · 2023: 11 · 2022: 19 · 2021: 17 · 2020: 18 · 2019: 11 · 2018: 11 · 2017: 10 · 2016: 25 · 2015: 16 · 2014: 28 · 2013: 27 · 2012: 29
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- National Institutes of Health (CA-25874)
- National Cancer Institute (CA09171, CA-25874, CA-76367, R01CA076367, P01CA025874, T32CA009171)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- Chk2, DNA damage checkpoint, p53 stabilization, MDM2, G1 cell cycle arrest, Cdc25C phosphorylation, post-translational modification, tumor suppressor proteins, dominant-negative mutant
- MeSH terms
- DNA Damage, Humans, Nuclear Proteins, Phosphorylation, Protein Kinases, Proto-Oncogene Proteins, Tumor Cells, Cultured, Tumor Suppressor Protein p53, G1 Phase, Protein Serine-Threonine Kinases, Schizosaccharomyces pombe Proteins, Proto-Oncogene Proteins c-mdm2, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
